Pharmafile Logo
Pharmafocus logo
Advanced Search

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015
Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …

News

Cost of diabetes treatment in England rises

August 12, 2015
Manufacturing and Production, Sales and Marketing HSCIC, NHS, diabetes, health and social care information centre, prescribing

As diabetes patients increase in numbers the cost of treating the disease in England has increased to more than £800 …

News
contrave

Orexigen and Takeda reboot Contrave collaboration

August 12, 2015
Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …

News
Kim Kardashian West Diclegis post

FDA warns drugmaker over Kim Kardashian West promo

August 12, 2015
Sales and Marketing Diclegis, Duchesnay, FDA, kim kardashian

Model and media personality Kim Kardashian West’s social media promotion of the morning sickness drug Diclegis has landed its producer …

News
Novavax

Novavax rides high on crest of RSV vaccine wave

August 12, 2015
Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines

The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …

News
gareth-thurston-web

Gareth Thurston joins Cello Health Consulting

August 12, 2015
Medical Communications Cello, Gareth Thurston, cello health

Cello Health has appointed Gareth Thurston as a consultant following his prior experience in pharmaceutical marketing. Gareth has over 20 …

Appointment
Opdivo

Bristol-Myers Squibb launches Opdivo in the UK for lung cancer

August 12, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, NSCLC, immunotherapy, lung cancer, non small cell lung cancer, non-small cell lung cancer, opdivo

The immuno-oncology drug Opdivo is available in the UK for people with lung cancer, after Bristol-Myers Squibb launched the drug …

News
Daiichi Sankyo

Daiichi scores another NICE nod for Lixiana

August 12, 2015
Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban

NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …

News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015
Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …

News
aprecias_zipdose_technology_in_action

Aprecia boosts 3D printing facilities at new US site

August 11, 2015
Manufacturing and Production, Research and Development

Aprecia Pharmaceuticals, which scored a world-first by becoming the first manufacturer to gain FDA approval for a three-dimensional printed (3DP) …

News
world map

Cold chain management and transportation of medicines

August 11, 2015
Manufacturing and Production CEIV, IATA, Transport, cold chain, fly pharma, fly pharma conference, logistics, supply chain, transportation, vaccines

Riekert Bruinink, a member of the guideline drafting committee and the Dutch health inspectorate, has a very simple explanation of …

Feature
Pharma pill manufacturing

US to lead global contract manufacturing market by 2020

August 11, 2015
Manufacturing and Production APIs, United States, manufacturing, production

The global pharmaceutical contract manufacturing market was worth $58 billion in 2014 and is projected to reach $84 billion in 2020, according to a …

News
George Freeman

UK medical innovation backed with £18m Biomedical Catalyst fund

August 10, 2015
Research and Development, Sales and Marketing

Life Sciences Minister George Freeman has announced an £18 million fund for the next generation of UK medical advances. Twelve …

News
R&D

Sanofi, Evotec and Apeiron partner on immuno-oncology

August 10, 2015
Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours

Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …

News
Nucynta (tapentadol)

Takeover hostilities resume between Depomed and Horizon

August 10, 2015
Sales and Marketing Depomed, horizon, hostile bid, nucynta, takeover, tapentadol

The bitter takeover row between Horizon and Depomed has escalated after Depomed dismissed its suitor’s latest advances, and warned it …

News
Health secretary Jeremy Hunt

Price tags on medicine packs a “headline grabbing gimmick”

August 7, 2015
Manufacturing and Production, Medical Communications Drug pricing, Jeremy Hunt, NHS, adherence, compliance

Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …

News

Pharma companies ‘using more in-house digital teams’

August 7, 2015
Medical Communications Med Comms, advertising, agencies, branding, communications, medical communications, social media

Fewer pharma companies are moving away from using external agencies for their digital marketing, a US survey has found.A study …

News
MyHeart Counts ResearchKit app

First Apple ResearchKit app launches in the UK

August 7, 2015
Medical Communications Apple, clinical trial, heart disease, researchkit, strokes

The first ResearchKit app to be made available to users outside of the US has launched in the UK. The …

News
bedrock

Bedrock Healthcare Communications makes new hires

August 6, 2015
Medical Communications Bedrock Healthcare Communications

Bedrock Healthcare Communications has made several new additions to the team.Sam Simpson joins as account director, Francesca Worthington as account …

Appointment

Pfizer and Flynn rapped for overcharging on anti-epilepsy drug

August 6, 2015
Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing

Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026